Access the full text.
Sign up today, get DeepDyve free for 14 days.
Naoto Mizumura, S. Okumura, Sho Toyoda, Atsuo Imagawa, M. Ogawa, Masayasu Kawasaki (2016)
Non‐traumatic bladder rupture showing less than 10 Hounsfield units of ascitesAcute Medicine & Surgery, 4
A. Fazlıoğlu, Z. Tandoğdu, F. Kurtuluş, Oğuzhan Parlakkiliç, M. Çek (2009)
Perivesical Inflammation and Necrosis due to Mitomycin C Instillation after Transurethral Resection of Bladder Tumor: We Must Be Vigilant!Urologia Internationalis, 83
D. Lim, J. Izawa, P. Middlebrook, J. Chin (2013)
Bladder perforation after immediate postoperative intravesical instillation of mitomycin C.Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 4 1
M. Asín, M. Fernández-Ruiz, F. López‐Medrano, C. Lumbreras, Á. Tejido, R. Juan, A. Arrébola-Pajares, M. Lizasoáin, S. Prieto, J. Aguado (2014)
Bacillus Calmette-Guérin (BCG) Infection Following Intravesical BCG Administration as Adjunctive Therapy For Bladder CancerMedicine, 93
M Brausi, J Oddens, R Sylvester (2014)
Side effects of Bacillus Calmette–Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCGEur Urol, 65
R. Gomez, Lily Ceballos, M. Coburn, J. Corriere, C. Dixon, B. Lobel, J. Mcaninch (2004)
Consensus statement on bladder injuriesBJU International, 94
L. Macleod, Tin Ngo, M. Gonzalgo (2014)
Complications of intravesical bacillus calmette-guérin.Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 8 7-8
MA Pérez-Jacoiste Asín, M Fernández-Ruiz, F López-Medrano (2014)
Bacillus Calmette–Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literatureMedicine (Baltimore), 93
J. Eswara, Valary Raup, A. Potretzke, S. Hunt, S. Brandes (2015)
Outcomes of Iatrogenic Genitourinary Injuries During Colorectal Surgery.Urology, 86 6
Madhusudan Koya, M. Simon, M. Soloway (2006)
Complications of intravesical therapy for urothelial cancer of the bladder.The Journal of urology, 175 6
C. Zhan, P. Maria, R. Dym (2017)
Intraperitoneal Urinary Bladder Perforation with Pneumoperitoneum in Association with Indwelling Foley Catheter Diagnosed in Emergency Department.The Journal of emergency medicine, 53 5
AP Meijden, RJ Sylvester, W Oosterlinck (2003)
Maintenance Bacillus Calmette-increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III TrialEur Urol, 44
(2009)
Treatment of tuberculosis guidelines
A. Böhle, D. Jocham, P. Bock (2003)
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity.The Journal of urology, 169 1
S. Hinotsu, H. Akaza, S. Naito, S. Ozono, Y. Sumiyoshi, Sumio Noguchi, A. Yamaguchi, S. Nagamori, A. Terai, Y. Nasu, H. Kume, Y. Tomita, Yoshinori Tanaka, S. Samma, H. Uemura, H. Koga, T. Tsushima (2011)
Maintenance therapy with bacillus Calmette‐Guérin Connaught strain clearly prolongs recurrence‐free survival following transurethral resection of bladder tumour for non‐muscle‐invasive bladder cancerBJU International, 108
J. Gregg, B. McCormick, Li Wang, P. Cohen, Daniel Sun, D. Penson, J. Smith, P. Clark, Michael Cookson, D. Barocas, M. Resnick, K. Moses, Sam Chang (2016)
Short term complications from transurethral resection of bladder tumor.The Canadian journal of urology, 23 2
A. Meijden, R. Sylvester, W. Oosterlinck, W. Hoeltl, A. Bono (2003)
Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.European urology, 44 4
J. Pan, Mo Liu, Xing Zhou (2014)
Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysisFrontiers of Medicine, 8
We report a case of ureteral obstruction and sepsis induced by bladder perforation following intravesical bacillus Calmette–Guérin (BCG) that was successfully treated non-surgically. A 56-year-old man was diagnosed with non-muscle invasive bladder cancer. He was treated with intravesical BCG instillation after transurethral resection of the bladder tumor. Just before the 6th course of intravesical BCG, the patient was diagnosed with bladder perforation and developed ureteral obstruction and sepsis associated with BCG. He was treated successfully with an antituberculous agent, antimicrobial chemotherapy and percutaneous urine drainage. Bladder perforation associated with BCG is a very rare adverse event that causes severe sepsis.
International Cancer Conference Journal – Springer Journals
Published: May 31, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.